Annovis Bio Receives NYSE Non-Compliance Notice

Annovis Bio said it fell below NYSE Section 802.01B requirements, with an approximately 30-day average market capitalization of $48.4 million and a stockholders’ deficit. The company plans to submit a remediation plan within 45 days and has nine months to regain compliance.